137 related articles for article (PubMed ID: 12683621)
1. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.
Bailey D; Erb H; Williams L; Ruslander D; Hauck M
J Vet Intern Med; 2003; 17(2):199-205. PubMed ID: 12683621
[TBL] [Abstract][Full Text] [Related]
2. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and efficacy of a novel doxorubicin and carboplatin chemotherapy protocol for the treatment of canine appendicular osteosarcoma following limb amputation.
Lane A; Black M; Wyatt K
Aust Vet J; 2012 Mar; 90(3):69-74. PubMed ID: 22339117
[TBL] [Abstract][Full Text] [Related]
6. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma.
Selmic LE; Burton JH; Thamm DH; Withrow SJ; Lana SE
J Vet Intern Med; 2014; 28(2):554-63. PubMed ID: 24512451
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
[TBL] [Abstract][Full Text] [Related]
8. The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.
Marley K; Helfand SC; Edris WA; Mata JE; Gitelman AI; Medlock J; Séguin B
BMC Vet Res; 2013 Jan; 9():15. PubMed ID: 23331343
[TBL] [Abstract][Full Text] [Related]
9. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.
Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM
J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062
[TBL] [Abstract][Full Text] [Related]
10. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006).
Saam DE; Liptak JM; Stalker MJ; Chun R
J Am Vet Med Assoc; 2011 Jan; 238(2):195-206. PubMed ID: 21235373
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
[TBL] [Abstract][Full Text] [Related]
12. Adverse events and outcomes in dogs with appendicular osteosarcoma treated with limb amputation and a single subcutaneous infusion of carboplatin.
Santamaria AC; Simcock JO; Kuntz CA
J Am Vet Med Assoc; 2019 Aug; 255(3):345-351. PubMed ID: 31298641
[TBL] [Abstract][Full Text] [Related]
13. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs.
Kent MS; Strom A; London CA; Seguin B
J Vet Intern Med; 2004; 18(4):540-4. PubMed ID: 15320595
[TBL] [Abstract][Full Text] [Related]
14. Effects of the potassium-sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells.
Poon AC; Inkol JM; Luu AK; Mutsaers AJ
J Vet Intern Med; 2019 Mar; 33(2):800-811. PubMed ID: 30556178
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study.
Moore AS; Dernell WS; Ogilvie GK; Kristal O; Elmslie R; Kitchell B; Susaneck S; Rosenthal R; Klein MK; Obradovich J; Legendre A; Haddad T; Hahn K; Powers BE; Warren D
J Vet Intern Med; 2007; 21(4):783-90. PubMed ID: 17708400
[TBL] [Abstract][Full Text] [Related]
16. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.
Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM
J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma.
Marley K; Helfand SC; Simpson J; Mata JE; Tracewell WG; Brownlee L; Bracha S; Séguin B
J Exp Clin Cancer Res; 2013 Oct; 32(1):74. PubMed ID: 24422857
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma: a pilot study.
Chun R; Kurzman ID; Couto CG; Klausner J; Henry C; MacEwen EG
J Vet Intern Med; 2000; 14(5):495-8. PubMed ID: 11012111
[TBL] [Abstract][Full Text] [Related]
19. Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study.
Barrett LE; Gardner HL; Barber LG; Sadowski A; London CA
BMC Vet Res; 2019 Aug; 15(1):291. PubMed ID: 31409327
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy.
Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ
J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
